These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 18691969)

  • 1. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
    Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
    Kim ET; Kim KK; Matunis MJ; Ahn JH
    Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
    J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
    Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
    Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
    Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
    PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
    Sekiyama N; Arita K; Ikeda Y; Hashiguchi K; Ariyoshi M; Tochio H; Saitoh H; Shirakawa M
    Proteins; 2010 May; 78(6):1491-502. PubMed ID: 20077568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
    J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
    Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
    J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
    J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
    Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
    EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO modification of the ubiquitin-conjugating enzyme E2-25K.
    Pichler A; Knipscheer P; Oberhofer E; van Dijk WJ; Körner R; Olsen JV; Jentsch S; Melchior F; Sixma TK
    Nat Struct Mol Biol; 2005 Mar; 12(3):264-9. PubMed ID: 15723079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.